Concepedia

Publication | Open Access

Targeting the CSF1/CSF1R axis is a potential treatment strategy for malignant meningiomas

DOIFull Paper Access

81

Citations

42

References

2021

Year

Jacky T. Yeung, Vesal Yaghoobi, Danielle Miyagishima, Matthew D. Vesely, Tianxiang Zhang, Ti Badri, Ala F. Nassar, Xue Han, Miguel F. Sanmamed, Mark W. Youngblood,
Neuro-Oncology

Abstract

Our findings suggest that anti-CSF1/CSF1R antibody treatment may be an effective normalization cancer immunotherapy for malignant meningiomas.

References

YearCitations

Page 1